RE:RE:RE:RE:RE:GCARRE: GCAR From 07 March Transcript.
"We continue to develop a study protocol that utilizes an adaptive design, building on the positive results from the GOBLET study. The registrational strategy for PDAC will incorporate learnings from our previous interactions with the Pancreatic Cancer Action Network also known as PanCAN, and ongoing conversations with their newly announced alliance partner, the Global Coalition for Adaptive Research or GCAR. As a result of these relationships, we've been able to collaborate with key opinion leaders in the pancreatic cancer community, and their enthusiasm for pela's potential in this indication reinforces our commitment to bringing new treatment options to patients."
Cheers!!!!!!!!!!!!!!!!!!!!!!